Sale of shares to board member

Anders Lönner, CEO of Meda AB, sold 5,000 shares in Meda to Marianne Hamilton, a Meda board member. After the sale, Lönner holdings in Meda total 2,228,132 shares and 700,000 warrants.

About Us

Meda is one of Europe's leading specialty pharma companies, with focus on marketing and market-adapted product development. Long-term partnerships and acquisitions are fundamental factors in its strategy.


Documents & Links